Refine by
Oncology Development Articles & Analysis
5 articles found
Alfa Cytology, which stands at the forefront of oncology service provision in New York United States, has announced its sophisticated antibody-drug conjugates(ADCs) development services for cancer. ...
Oncology drug development makes up almost half of the annual R&D expenditure of biopharmaceutical companies. ...
Alfa Cytology has announced its small molecule drug development to advance preclinical cancer research. Alfa Cytology, a comprehensive biotech company specializing in cancer research, has recently announced the cancer small molecule drug development services. ...
Ongoing research and inventions in the field of oncology focus on the development of small molecule drug therapies for use in brain tumor resection. Small molecule drugs are being developed to target and effectively treat brain tumors to improve therapeutic outcomes. ...
Snyder to Navigating Cancer’s Board and especially value her point of view as a recognized leader in oncology and therapeutic development,” said Bill Bunker, Navigating Cancer’s CEO. ...